Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized meningococcal group A,C conjugate vaccine in infants
CTR20140065Phase 3Completed
- Sponsor
- Wuhan Institute of Biological Products
- Start
- Mar 2014
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of A,C Meningococcal Conjugate Vaccine (freeze-dried) in meningococcal disease, Serogroup C meningococcal disease (MenC), sponsored by Wuhan Institute of Biological Products. Started Mar 2014; status: completed.
02
Drugs
A,C Meningococcal Conjugate Vaccine (freeze-dried)
03
Conditions
meningococcal diseaseSerogroup C meningococcal disease (MenC)
Beyond the preview
Go deeper on CTR20140065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140065.